KLRF1 Human Pre-designed siRNA Set A contains three designed siRNAs for KLRF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLRG1 Human Pre-designed siRNA Set A contains three designed siRNAs for KLRG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLRG2 Human Pre-designed siRNA Set A contains three designed siRNAs for KLRG2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLRK1 Human Pre-designed siRNA Set A contains three designed siRNAs for KLRK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KME-2780 is a potent and selective dual IRAK1 and IRAK4 inhibitor and can be used for research of dysregulation of innate immune signaling and hematologic malignancies[1].

KMG-301AM TFA is the acetoxy methyl esterified form of KMG-301. KMG-301AM TFA successfully accumulates in mitochondria and then it is hydrolyzed to KMG-301. KMG-301 is an Mg2+-selective fluorescent probe functional in mitochondria in intact cells. Since the mitochondrial membrane is impermeable to KMG-301, it is not released upon depolarization of the mitochondrial membrane potential. KMG-301 […]

KMO Human Pre-designed siRNA Set A contains three designed siRNAs for KMO gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KMT2A Human Pre-designed siRNA Set A contains three designed siRNAs for KMT2A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KMT2B Human Pre-designed siRNA Set A contains three designed siRNAs for KMT2B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KMT2C Human Pre-designed siRNA Set A contains three designed siRNAs for KMT2C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KMT2D Human Pre-designed siRNA Set A contains three designed siRNAs for KMT2D gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KMT2E Human Pre-designed siRNA Set A contains three designed siRNAs for KMT2E gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KMT5A Human Pre-designed siRNA Set A contains three designed siRNAs for KMT5A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KMT5B Human Pre-designed siRNA Set A contains three designed siRNAs for KMT5B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KMT5C Human Pre-designed siRNA Set A contains three designed siRNAs for KMT5C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KN-17 is a modified based on the structure of cecropin B (HY-P0092), can effectively interfere with bacterial growth and induce the migration of human bone marrow stromal cells (hBMSCs). KN-17 can significantly stimulate angiogenesis in vitro and in vivo[1].

KNCN Human Pre-designed siRNA Set A contains three designed siRNAs for KNCN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KNDC1 Human Pre-designed siRNA Set A contains three designed siRNAs for KNDC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KNG1 Human Pre-designed siRNA Set A contains three designed siRNAs for KNG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KNL1 Human Pre-designed siRNA Set A contains three designed siRNAs for KNL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KNSTRN Human Pre-designed siRNA Set A contains three designed siRNAs for KNSTRN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KNTC1 Human Pre-designed siRNA Set A contains three designed siRNAs for KNTC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Kojic acid-13C6 is 13C labeled 2,3-Pentanedione (HY-W012998). 2,3-Pentanedione is a common constituent of synthetic flavorings and is used to impart a butter, strawberry, caramel, fruit, rum, or cheese flavor in beverages, ice cream, candy, baked goods, gelatins, and puddings. 2,3-Pentanedione also occurs naturally as a fermentation product in beer, wine, and yogurt and is releasedduring […]

Kokusaginine is a furoquinoline alkaloids, which exhibits inhibitory efficacy for acetylcholinesterase (AChE) with an IC50 of 28.2 μM. Kokusaginine exhibits anti-proliferative and apoptotic inducing effects in MCF-7/ADR cells[1][2].

KP-457 is a selective a disintegrin and metalloproteinase 17 (ADAM17) inhibitor, with higher selectivity for ADAM17 than for other MMPs and ADAM10, and IC50s are 11.1 nM (ADAM17), 748 nM (ADAM10), 717 nM (MMP2), 9760 nM (MMP3), 2200 nM (MMP8), 5410 nM (MMP9), 930 nM (MMP13), 2140 nM (MMP14), and 7100 nM (MMP17), respectively.

KP-457 is a selective a disintegrin and metalloproteinase 17 (ADAM17) inhibitor, with higher selectivity for ADAM17 than for other MMPs and ADAM10, and IC50s are 11.1 nM (ADAM17), 748 nM (ADAM10), 717 nM (MMP2), 9760 nM (MMP3), 2200 nM (MMP8), 5410 nM (MMP9), 930 nM (MMP13), 2140 nM (MMP14), and 7100 nM (MMP17), respectively.

KP-457 is a selective a disintegrin and metalloproteinase 17 (ADAM17) inhibitor, with higher selectivity for ADAM17 than for other MMPs and ADAM10, and IC50s are 11.1 nM (ADAM17), 748 nM (ADAM10), 717 nM (MMP2), 9760 nM (MMP3), 2200 nM (MMP8), 5410 nM (MMP9), 930 nM (MMP13), 2140 nM (MMP14), and 7100 nM (MMP17), respectively.

KP-457 is a selective a disintegrin and metalloproteinase 17 (ADAM17) inhibitor, with higher selectivity for ADAM17 than for other MMPs and ADAM10, and IC50s are 11.1 nM (ADAM17), 748 nM (ADAM10), 717 nM (MMP2), 9760 nM (MMP3), 2200 nM (MMP8), 5410 nM (MMP9), 930 nM (MMP13), 2140 nM (MMP14), and 7100 nM (MMP17), respectively.

KP-457 is a selective a disintegrin and metalloproteinase 17 (ADAM17) inhibitor, with higher selectivity for ADAM17 than for other MMPs and ADAM10, and IC50s are 11.1 nM (ADAM17), 748 nM (ADAM10), 717 nM (MMP2), 9760 nM (MMP3), 2200 nM (MMP8), 5410 nM (MMP9), 930 nM (MMP13), 2140 nM (MMP14), and 7100 nM (MMP17), respectively.

KPNA1 Human Pre-designed siRNA Set A contains three designed siRNAs for KPNA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KPNA2 Human Pre-designed siRNA Set A contains three designed siRNAs for KPNA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KPNA3 Human Pre-designed siRNA Set A contains three designed siRNAs for KPNA3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KPNA4 Human Pre-designed siRNA Set A contains three designed siRNAs for KPNA4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KPNA5 Human Pre-designed siRNA Set A contains three designed siRNAs for KPNA5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KPNA6 Human Pre-designed siRNA Set A contains three designed siRNAs for KPNA6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KPNA7 Human Pre-designed siRNA Set A contains three designed siRNAs for KPNA7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KPNB1 Human Pre-designed siRNA Set A contains three designed siRNAs for KPNB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KPRP Human Pre-designed siRNA Set A contains three designed siRNAs for KPRP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KPTN Human Pre-designed siRNA Set A contains three designed siRNAs for KPTN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KR-12 human is an active segment of LL-37, which exhibits antimicrobial activity against gram-negative bacteria. KR-12 human inhibits E. coli K-12 with MIC of 66 μM[1].

KR-27370 (compound 7f) is an antiviral agent and selective PI4KIIIβ/PI4KIIIα inhibitor (IC50: 3.1 nM/15.8 nM), against hRV, Ke Saatchivirus and other enteroviruses have inhibitory activity[1].br/[1].

KRAS G12D inhibitor 20 (Compound 14) is a selective G12D KRAS inhibitor. KRAS G12D inhibitor 20 has antitumor activity[1].

KRAS Human Pre-designed siRNA Set A contains three designed siRNAs for KRAS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KRAS ligand 4 (Compound 2) is a bifunctional depressant based on SOS1. KRAS ligand 4 reduces the downstream signaling markers pERK and pS6 and shows anti-proliferative activity in multiple KRAS mutated cells[1].